1 completed, 1 unknown. 1 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow MAD0004J08: new trials by email Literature Review of MAD0004J08 trials Research Report on MAD0004J08
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Select the Dose and Evaluate Safety and Efficacy of Monoclonal Antibody in Adult With Recently Diagnosed Asymptomatic to Moderately Severe COVID-19. MAD0004J08, Placebo - Covid19 | Phase 2 / Phase 3 | Unknown | Toscana Life Sciences Sviluppo s.r.l. | 800 | 2021-06-06 | 2022-02-03 |
| Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease. MAD0004J08, Placebo - COVID-19 Virus Disease | Phase 1 | Completed | Toscana Life Sciences Sviluppo s.r.l. | 30 | 2021-03-01 | 2022-04-27 |
COVID-19 (2)
Toscana Life Sciences Sviluppo s.r.l. (2)
Italy (2)
Andrea Paolini (1) · Simone Lanini (1)